Response to Vaccination in Infants Exposed to Antitumor Necrosis Factor Alpha In Utero
- PMID: 34260494
- DOI: 10.1097/INF.0000000000003271
Response to Vaccination in Infants Exposed to Antitumor Necrosis Factor Alpha In Utero
Abstract
In this retrospective cohort study, the response to routinely administered Haemophilus influenzae type B vaccine, pneumococcal and pertussis vaccinations in 27 children exposed to antitumor necrosis factor alpha (anti-TNFα) during pregnancy was measured. The overall vaccination response seems comparable for children exposed to anti-TNFα and healthy infants. After primary vaccination series, inadequate response was present in some patients and might be related to exposure to anti-TNFα.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
J.W.W. had received a research grant from the Dr CJ Vaillant Foundation. G.D. had received a research grant from Elisabeth von Freyburg, research grant Sophia Research Foundation and a research grant Dr CJ Vaillant Foundation. R.H.T.B. is a member of the Nutricia advisory board. The other authors have no conflicts of interest to disclose.
References
-
- Nguyen GC, Seow CH, Maxwell C, et alIBD in Pregnancy Consensus Group; Canadian Association of GastroenterologyThe Toronto Consensus Statements for the management of inflammatory bowel disease in pregnancy.Gastroenterology.2016150734757.e1
-
- Julsgaard M, Christensen LA, Gibson PR, et al. Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection.Gastroenterology.2016151110119
-
- Cheent K, Nolan J, Shariq S, et al. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn’s disease.J Crohns Colitis.20104603605
-
- Duricova D, Dvorakova E, Hradsky O, et al. Safety of anti-TNF-alpha therapy during pregnancy on long-term outcome of exposed children: a controlled, multicenter observation.Inflamm Bowel Dis.201925789796
-
- Beaulieu DB, Ananthakrishnan AN, Martin C, et al. Use of biologic therapy by pregnant women with inflammatory bowel disease does not affect infant response to vaccines.Clin Gastroenterol Hepatol.20181699105
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
